The Evaluation of Human Tenon's Fibroblasts and Endothelial Cell Responses to Antifibrotics Alone and in Combination with α-Tocopherol. (January 2015)
- Record Type:
- Journal Article
- Title:
- The Evaluation of Human Tenon's Fibroblasts and Endothelial Cell Responses to Antifibrotics Alone and in Combination with α-Tocopherol. (January 2015)
- Main Title:
- The Evaluation of Human Tenon's Fibroblasts and Endothelial Cell Responses to Antifibrotics Alone and in Combination with α-Tocopherol
- Authors:
- Engin, Kaya N.
Erdem-Kuruca, Serap
Akgün-Dar, Kadriye
Çetin, Beyza
Karadenizli, Sabriye
Gürel, Ebru
Yemisci, Bülent
Bilgiç, Sema
Arslan, Mehmet - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Purpose</italic>: We aimed to evaluate the influence of current antifibrotic agents as well as the possible results obtained by combining these agents. This study included α-tocopherol, a strong antifibrotic and an efficient neuromediator of pathways used by other agents.</p> <p> <italic>Materials and Methods</italic>: Mitochondrial <italic>Bcl-2, Bax</italic>, cytochrome c and cytoplasmic caspase-3 expression, as well as toxic effect patterns, mitosis and cellular reactions due to α-tocopherol alone or combined with paclitaxel, mitomycin C and 5-flurouracil (5-FU), was studied in series obtained from human endothelial and primary Tenon's fibroblast cell cultures.</p> <p> <italic>Results</italic>: The strongest apoptotic effect in both cell groups belonged to paclitaxel, followed by mitomycin C, and despite the overall suppressive effect of the α-tocopherol combination, mitomycin C increased its efficiency on the endothelial cells. The apoptosis/necrosis ratio was highest in α-tocopherol and lowest in paclitaxel, with α-tocopherol generally decreasing necrosis. <italic>Bax</italic> was observed at a high level with mitomycin C. Cytotoxicity was the highest with paclitaxel, and the caspase-3 reaction was markedly higher with mitomycin C in both cell types. In the α-tocopherol and 5-FU slides, mitosis and a layered formation were observed. The addition of α-tocopherol reduced the cytotoxicity of all antifibrotic agents in both<abstract> <title>Abstract</title> <p> <italic>Purpose</italic>: We aimed to evaluate the influence of current antifibrotic agents as well as the possible results obtained by combining these agents. This study included α-tocopherol, a strong antifibrotic and an efficient neuromediator of pathways used by other agents.</p> <p> <italic>Materials and Methods</italic>: Mitochondrial <italic>Bcl-2, Bax</italic>, cytochrome c and cytoplasmic caspase-3 expression, as well as toxic effect patterns, mitosis and cellular reactions due to α-tocopherol alone or combined with paclitaxel, mitomycin C and 5-flurouracil (5-FU), was studied in series obtained from human endothelial and primary Tenon's fibroblast cell cultures.</p> <p> <italic>Results</italic>: The strongest apoptotic effect in both cell groups belonged to paclitaxel, followed by mitomycin C, and despite the overall suppressive effect of the α-tocopherol combination, mitomycin C increased its efficiency on the endothelial cells. The apoptosis/necrosis ratio was highest in α-tocopherol and lowest in paclitaxel, with α-tocopherol generally decreasing necrosis. <italic>Bax</italic> was observed at a high level with mitomycin C. Cytotoxicity was the highest with paclitaxel, and the caspase-3 reaction was markedly higher with mitomycin C in both cell types. In the α-tocopherol and 5-FU slides, mitosis and a layered formation were observed. The addition of α-tocopherol reduced the cytotoxicity of all antifibrotic agents in both cell series by decreasing the cell numbers, leading to necrosis.</p> <p> <italic>Conclusions</italic>: Alone or in combination, the use of α-tocopherol and 5-FU is safer than other agents. By suppressing the cytotoxic effects of other antifibrotic agents, α-tocopherol is a promising drug for improving the effects of antifibrotics in many aspects of medicine. In addition, it has the potential to play a role beyond its antioxidant and antifibrotic activity in ocular surgery.</p> </abstract> … (more)
- Is Part Of:
- Current eye research. Volume 40:Number 1(2015:Jan.)
- Journal:
- Current eye research
- Issue:
- Volume 40:Number 1(2015:Jan.)
- Issue Display:
- Volume 40, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 40
- Issue:
- 1
- Issue Sort Value:
- 2015-0040-0001-0000
- Page Start:
- 19
- Page End:
- 29
- Publication Date:
- 2015-01
- Subjects:
- Ophthalmology -- Periodicals
Eye -- Diseases -- Periodicals
Ophthalmology -- Periodicals
573.88 - Journal URLs:
- http://informahealthcare.com/journal/cey ↗
http://www.tandfonline.com/toc/icey20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/02713683.2014.909496 ↗
- Languages:
- English
- ISSNs:
- 0271-3683
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3496.570000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3889.xml